Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial

BACKGROUND: Intensification of therapy may improve outcomes for patients with high-risk localized prostate cancer. OBJECTIVE: To provide long-term follow-up data from phase III RTOG 0521, which compared a combination of androgen deprivation therapy (ADT) + external beam radiation therapy (EBRT) + do...

Descripción completa

Detalles Bibliográficos
Autores principales: Sartor, Oliver, Karrison, Theodore G., Sandler, Howard M., Gomella, Leonard G., Amin, Mahul B., Purdy, James, Michalski, Jeff M., Garzotto, Mark G., Pervez, Nadeem, Balogh, Alexander G., Rodrigues, George B., Souhami, Luis, Neil Reaume, M., Williams, Scott G., Hannan, Raquibul, Jones, Christopher U., Horwitz, Eric M., Rodgers, Joseph P., Feng, Felix Y., Rosenthal, Seth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662642/
https://www.ncbi.nlm.nih.gov/pubmed/37179241
http://dx.doi.org/10.1016/j.eururo.2023.04.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662642/
https://www.ncbi.nlm.nih.gov/pubmed/37179241
http://dx.doi.org/10.1016/j.eururo.2023.04.024

Ejemplares similares